See also this year's filing and all EDGAR filings for this company.
PDF Report 0001553643_2026_Relmada_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001553643, Relmada Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 93,983,971 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 19,500 |
| 4 | LiabilitiesCurrent | 6,430,527 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,060,931 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,344,948 |
| 9 | ResearchAndDevelopmentExpense | 13,606,120 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 2,450,708 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 94,003,471 |
| 1 | Liabilities | 7,491,458 |
| 2 | Expenses | 44,951,068 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 86,512,013 |
| 5 | NetIncome | -42,500,360 |
| 6 | ComprehensiveNetIncome | -42,500,360 |
| 7 | BaseVar | 74,448,352 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.88 |
| 9 | EconomicCapitalRatio | 3.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
